Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

Dignitana AB: University Hospital Schleswig-Holstein in Kiel, Germany selects DigniCap

Dignitana

Dignitana AB (http://www.dignitana.com/)announces that the highly ranked University HospitalSchleswig-Holstein (http://www.unifrauenklinik-kiel.de/) (UKSH) in Kiel, Germany will offer DigniCap for patients at the Clinic for Gynecology and Obstetrics.

The clinic acquired two DigniCap Delta devices and the staff completed the training in October. UKSH chose DigniCap based on the advanced technology in the DigniCap Delta device which is designed to improve patient outcomes and ease of use.

"UKSH offers patients comprehensive cancer care with the most advanced diagnostics and treatments. The quality-of-life benefits of DigniCap align well with our integrative approach to cancer care, and we have already seen strong patient demand for DigniCap," said PDDr.med. Mohamed Elessawy, M.D., Clinic for Gynecology and Obstetrics University Hospital Schleswig-Holstein, Kiel Campus who has led the introduction of DigniCap to the medical center.

"UKSH is a prominent leader in cancer care are we are excited to make DigniCap available to UKSH patients providing access to the next generation technology found only in DigniCap Delta," said Fredrik Jonsson, Dignitana CEO.

The University Medical Center Schleswig-Holstein (UKSH) is a top medical institution in northern Germany, offering specialized, high-quality cancer care. Recognized and funded by German Cancer Aid as an Oncology Center of Excellence, UKSH is one of Europe's most advanced medical centers.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.